Ionel Mangalagiu

Prof. Ionel Mangalagiu serves as Professor at the Department of Exact and Natural Sciences, Alexandru Ioan Cuza University, Iași, Romania, and leads research at the CERNESIM Center. His career spans over two decades with continuous contributions to heterocyclic chemistry, maintaining active publication and grant leadership through 2025.

His research program integrates three interconnected domains:

• Chemistry and Health: Design of azaheterocyclic compounds as potential drugs for cancer, HIV, tuberculosis, and antimicrobial applications, including Alzheimer's disease treatment and agricultural growth factors.
• Chemistry and Nanosciences: Development of fluorescent nanomaterials, molecular logic gates, chemosensors, and azacryptands for optoelectronic applications.
• Chemistry and Environment: Pioneering eco-friendly synthesis using microwaves and ultrasound to minimize environmental impact while maintaining reaction efficiency.

His methodology combines organic synthesis, computational modeling, and biological validation.

Analysis of recent publications (2023-2025) reveals a strategic shift toward hybrid heterocyclic architectures with dual anticancer-antimicrobial functionality. Key trends include the dominance of indolizine, phenanthridine, and diazine scaffolds, systematic application of green synthesis protocols, and exploitation of fluorescent properties for sensing applications. Computational tools increasingly guide molecular design and activity prediction.

Prof. Mangalagiu has secured 12 major research projects totaling over 1.5 million Euros from NATO, EU FP7, COST, and Romanian funding agencies. These initiatives address antimicrobial resistance (CED-Antim project), nanomaterials for medical devices (NanoTP), and sustainable chemistry (Synthesis of Highly Fluorescent Materials). While specific student names aren't listed, his grant leadership implies extensive mentorship in synthetic chemistry and drug discovery.

His laboratory operates within the CERNESIM Center, which provides advanced infrastructure for heterocyclic synthesis, nanomaterials characterization, and biological testing. The center maintains active collaborations with European research institutions under Horizon 2020 frameworks, focusing on translating chemical innovations into pharmaceutical and environmental applications.